https://www.organon.com/suppliers/news/merck-to-focus-on-key-growth-pillars-through-spinoff-of-womens-health-trusted-legacy-brands-and-biosimilars-products-into-new-company-newco/ 2020-02-05T06:45:00+00:00 https://www.organon.com/suppliers/news/merck-announces-organon-co-as-new-company-name-for-planned-spinoff/ 2020-03-11T09:00:00+00:00 https://www.organon.com/suppliers/news/merck-announces-appointment-of-organon-co-chief-financial-officer-and-chief-information-officer/ 2020-05-18T16:30:00+00:00 https://www.organon.com/suppliers/news/merck-announces-appointment-of-organon-co-general-counsel/ 2020-07-08T16:30:00+00:00 https://www.organon.com/suppliers/news/merck-announces-filing-of-form-10-registration-statement-in-connection-with-planned-spinoff-of-organon-co/ 2021-03-17T16:27:00+00:00 https://www.organon.com/suppliers/news/merck-announces-acquisition-of-alydia-health-on-behalf-of-its-planned-spinoff-of-organon/ 2021-03-30T07:30:00+00:00 https://www.organon.com/suppliers/news/merck-to-hold-investor-briefing-featuring-organon-on-may-3/ 2021-04-27T06:47:00+00:00 https://www.organon.com/suppliers/news/merck-hosts-organon-investor-day-outlining-new-companys-vision-focus-and-business-model-for-sustained-growth/ 2021-05-03T06:45:00+00:00 https://www.organon.com/suppliers/news/organon-launches-as-new-global-womens-health-company/ 2021-06-03T00:01:00+00:00 https://www.organon.com/suppliers/news/organon-completes-acquisition-of-alydia-health-a-medical-device-company-focused-on-postpartum-hemorrhage/ 2021-06-16T08:30:00+00:00 https://www.organon.com/suppliers/news/organon-announces-filing-of-form-10-q-for-the-quarter-ended-march-31-2021/ 2021-06-21T08:30:00+00:00 https://www.organon.com/suppliers/news/organon-recommends-stockholders-reject-below-market-mini-tender-offer-by-trc-capital-investment-corporation/ 2021-06-29T09:05:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-fiscal-q2-results-and-host-conference-call-on-august-12-2021/ 2021-07-22T08:30:00+00:00 https://www.organon.com/suppliers/news/organon-and-obseva-enter-global-license-agreement-to-develop-and-commercialize-ebopiprant-obe022-an-investigational-agent-being-evaluated-as-a-first-in-class-treatment-for-preterm-labor/ 2021-07-27T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-second-quarter-ended-june-30-2021-and-announces-inaugural-dividend/ 2021-08-12T07:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-citis-16th-annual-biopharma-virtual-conference/ 2021-09-01T08:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-morgan-stanleys-19th-annual-global-healthcare-virtual-conference/ 2021-09-01T08:15:00+00:00 https://www.organon.com/suppliers/news/organon-aims-to-ignite-worldwide-conversation-around-unplanned-pregnancy/ 2021-09-21T00:01:00+00:00 https://www.organon.com/suppliers/news/statement-on-vaccination-requirement/ 2021-09-29T14:10:42+00:00 https://www.organon.com/suppliers/news/organon-receives-fda-clearance-for-technological-updates-to-the-jada-system-a-medical-device-intended-to-control-postpartum-hemorrhage/ 2021-10-11T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-launches-new-fertility-journey-website-as-part-of-ongoing-commitment-to-help-address-the-needs-of-women/ 2021-10-15T06:50:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-third-quarter-results-and-host-conference-call-on-november-11-2021/ 2021-10-28T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-acquire-forendo-pharma/ 2021-11-11T06:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-third-quarter-ended-september-30-2021/ 2021-11-11T06:31:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-evercore-isi-4th-annual-healthconx-conference/ 2021-11-22T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-completes-acquisition-of-forendo-pharma/ 2021-12-13T09:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-40th-annual-j-p-morgan-healthcare-virtual-conference/ 2021-12-20T07:30:00+00:00 https://www.organon.com/suppliers/news/fda-accepts-samsung-bioepis-and-organons-sbla-for-their-citrate-free-high-concentration-humira-adalimumabbiosimilar-candidate/ 2022-01-05T06:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-fourth-quarter-and-full-year-results-and-host-conference-call-on-february-17-2022/ 2022-02-01T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-declares-paid-time-off-for-all-employees-on-international-womens-day-employees-to-focus-on-their-own-health-in-recognition-of-growing-womens-health-inequity/ 2022-02-02T07:00:00+00:00 https://www.organon.com/suppliers/news/organon-acquires-contraceptive-products-marvelon-and-mercilon-in-the-peoples-republic-of-china-including-hong-kong-and-macau-and-agrees-to-acquire-these-products-in-vietnam/ 2022-02-16T08:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-fourth-quarter-and-full-year-ended-december-31-2021/ 2022-02-17T06:30:00+00:00 https://www.organon.com/suppliers/news/meghan-rivera-appointed-us-managing-director-organon/ 2022-03-01T06:55:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-cowen-42nd-annual-healthcare-virtual-conference/ 2022-03-02T07:00:00+00:00 https://www.organon.com/suppliers/news/organon-enters-into-global-license-agreement-to-commercialize-dare-biosciences-xaciato-clindamycin-phosphate-vaginal-gel-2-fda-approved-treatment-for-females-12-and-older-with-ba/ 2022-03-31T07:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-first-quarter-results-and-host-conference-call-on-may-5-2022/ 2022-04-21T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-first-quarter-ended-march-31-2022/ 2022-05-05T07:30:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-fda-approves-dermavants-vtama-tapinarof-cream-1-for-the-treatment-of-plaque-psoriasis-in-adults-first-topical-novel-chemical-entity-launched-for-psoriasis/ 2022-05-24T00:00:00+00:00 https://www.organon.com/suppliers/news/on-one-year-anniversary-organon-introduces-global-esg-strategy-and-commitments-with-publication-of-inaugural-esg-report/ 2022-06-02T07:00:00+00:00 https://www.organon.com/suppliers/news/organon-enters-into-global-license-agreement-to-commercialize-henlius-investigational-perjeta-pertuzumab-and-prolia-xgeva-denosumab-biosimilar-candidates/ 2022-06-13T08:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-second-quarter-results-and-host-conference-call-on-august-4-2022/ 2022-07-21T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-and-cirqle-biomedical-enter-research-collaboration-and-license-agreement-for-investigational-non-hormonal-on-demand-contraceptive-candidate/ 2022-07-28T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-second-quarter-ended-june-30-2022/ 2022-08-04T07:30:00+00:00 https://www.organon.com/suppliers/news/samsung-bioepis-and-organon-announce-fda-approval-of-citrate-free-high-concentration-humira-biosimilar-hadlima-adalimumab-bwwd/ 2022-08-17T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-third-quarter-results-and-host-conference-call-on-november-3-2022/ 2022-10-20T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-third-quarter-ended-september-30-2022/ 2022-11-03T07:30:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-dermavant-announces-highly-favorable-results-from-pediatric-maximal-usage-study-of-vtama-tapinarof-cream-1-in-atopic-dermatitis/ 2022-11-08T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-announces-formal-commitment-to-fp2030-to-help-prevent-120-million-unintended-pregnancies-in-low-and-middle-income-countries-around-the-world/ 2022-11-14T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-piper-sandler-34th-annual-healthcare-conference/ 2022-11-15T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-appoints-kirke-weaver-as-general-counsel-and-corporate-secretary/ 2022-12-12T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/ 2022-12-15T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-makes-strategic-investment-in-claria-medical-to-support-development-of-investigational-medical-device-for-minimally-invasive-hysterectomy/ 2023-01-05T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-fourth-quarter-and-full-year-results-and-host-conference-call-on-february-16-2023/ 2023-02-06T07:30:00+00:00 https://www.organon.com/suppliers/news/ahead-of-international-womens-day-organon-calls-for-recognition-of-the-repercussions-of-underinvesting-in-womens-health/ 2023-02-07T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-fourth-quarter-and-full-year-ended-december-31-2022/ 2023-02-16T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-launches-her-plan-is-her-power-a-new-global-initiative-to-reduce-unplanned-pregnancies-where-need-is-great-and-disparities-exist/ 2023-03-07T07:00:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-dermavant-reports-positive-topline-results-from-adoring-2-atopic-dermatitis-phase-3-trial-of-vtama-tapinarof-cream-1-once-daily-in-adults-and-children-as-young-as-2/ 2023-03-15T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-first-quarter-and-host-conference-call-on-may-4-2023/ 2023-04-20T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-first-quarter-ended-march-31-2023/ 2023-05-04T07:30:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-dermavant-reports-positive-topline-results-from-adoring-1-the-second-atopic-dermatitis-phase-3-trial-of-vtama-tapinarof-cream-1-in-adults-and-children-as-young-as/ 2023-05-16T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-and-caf-development-bank-of-latin-america-launch-first-of-its-kind-collaboration-to-increase-sustainable-financing-in-womens-health/ 2023-06-07T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-publishes-fy2022-esg-report-showcasing-progress-toward-global-sustainability-goals/ 2023-06-27T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-samsung-bioepis-announce-us-launch-of-humira-biosimilar-hadlima-adalimumab-bwwd-in-multiple-presentations-consistent-with-originator/ 2023-07-01T06:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-second-quarter-results-and-host-conference-call-on-august-8-2023/ 2023-07-17T07:30:00+00:00 https://www.organon.com/suppliers/news/samsung-bioepis-organon-announce-topline-results-from-interchangeability-study-of-sb5-humira-biosimilar/ 2023-08-01T07:00:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-second-quarter-ended-june-30-2023/ 2023-08-08T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-bolsters-research-development-expertise-with-two-leadership-appointments/ 2023-09-05T10:00:00+00:00 https://www.organon.com/suppliers/news/first-real-world-observational-study-of-the-jadasystem-a-medical-device-to-control-postpartum-hemorrhage-pph-published-in-acogs-obstetrics-gynecology/ 2023-09-14T17:12:00+00:00 https://www.organon.com/suppliers/news/organon-recognized-on-fortunes-2023-change-the-world-list-for-leadership-in-expanding-access-to-contraceptive-choice/ 2023-09-27T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-third-quarter-results-and-host-conference-call-on-november-2-2023/ 2023-10-19T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-and-sempre-health-announce-collaboration-on-new-service-to-help-eligible-patients-save-money-and-stay-on-their-medication-as-prescribed/ 2023-11-01T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-third-quarter-ended-september-30-2023/ 2023-11-02T07:30:00+00:00 https://www.organon.com/suppliers/news/samsung-bioepis-organon-announce-fda-acceptance-of-supplemental-biologics-license-application-sbla-for-interchangeability-designation-for-hadlima-adalimumab-bwwd-a-biosimilar-to-humira/ 2023-11-07T16:15:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-piper-sandler-35th-annual-healthcare-conference/ 2023-11-21T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-announces-new-head-of-research-and-development/ 2023-12-05T00:00:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-dermavant-announces-positive-results-from-phase-4-open-label-trial-of-vtama-tapinarof-cream-1-for-the-treatment-of-plaque-psoriasis-in-the-head-and-neck-region-in-a/ 2023-12-06T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-lilly-enter-commercialization-agreement-in-europe-for-two-migraine-medicines/ 2023-12-18T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference/ 2023-12-21T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-affirms-2023-revenue-and-adjusted-ebitda-guidance-and-provides-2024-outlook/ 2024-01-08T07:30:00+00:00 https://www.organon.com/suppliers/news/organons-xaciato-clindamycin-phosphate-vaginal-gel-2-available-nationwide-to-treat-bacterial-vaginosis-bv-in-females-aged-12-and-older/ 2024-01-10T07:33:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-dermavant-announces-positive-data-from-the-adoring-phase-3-development-program-in-atopic-dermatitis-with-vtama-tapinarof-cream-1-in-adults-and-children-as-young-as/ 2024-01-11T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-fourth-quarter-and-full-year-results-and-host-conference-call-on-february-15-2024/ 2024-02-01T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-fourth-quarter-and-full-year-ended-december-31-2023/ 2024-02-15T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-launches-u-s-grant-programs-and-listening-tour-as-part-of-her-plan-is-her-power-reaching-high-need-communities-to-help-reduce-unplanned-pregnancies/ 2024-02-20T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-announces-hadlima-adalimumab-bwwd-has-been-exclusively-selected-by-the-us-department-of-veterans-affairs-va-replacing-humira-on-its-national-formulary/ 2024-02-20T08:00:00+00:00 https://www.organon.com/suppliers/news/phase-3-comparative-clinical-study-of-prolia-and-xgeva-denosumab-biosimilar-candidate-hlx14-met-primary-endpoints/ 2024-04-08T06:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-first-quarter-2024-results-and-host-conference-call-on-may-2-2024/ 2024-04-08T06:15:00+00:00 https://www.organon.com/suppliers/news/organons-hadlima-adalimumab-bwwd-and-nuvaring-etonogestrel-ethinyl-estradiol-vaginal-ring-added-to-mark-cubans-cost-plus-drugs/ 2024-04-15T00:00:00+00:00 https://www.organon.com/suppliers/news/dermavant-issued-release-dermavant-announces-fda-acceptance-of-supplemental-new-drug-application-snda-for-vtama-tapinarof-cream-1-for-the-treatment-of-atopic-dermatitis-in-adults-and-chil/ 2024-04-29T00:00:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-first-quarter-ended-march-31-2024/ 2024-05-02T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-announces-proposed-1-0-billion-senior-notes-offering/ 2024-05-07T07:58:00+00:00 https://www.organon.com/suppliers/news/organon-announces-pricing-of-1-0-billion-senior-notes-offering/ 2024-05-07T20:20:00+00:00 https://www.organon.com/suppliers/news/european-medicines-agency-ema-validates-henlius-and-organon-filings-for-prolia-and-xgeva-denosumab-biosimilar-candidate-hlx14/ 2024-05-24T06:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-second-quarter-2024-results-and-host-conference-call-on-august-6-2024/ 2024-07-09T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-second-quarter-ended-june-30-2024/ 2024-08-06T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-lilly-expand-migraine-commercialization-agreement-to-11-additional-markets/ 2024-08-20T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-appoints-daniel-karp-as-executive-vice-president-corporate-development/ 2024-09-03T07:30:00+00:00 https://www.organon.com/suppliers/news/og-8276a-for-dysmenorrhea-demonstrated-positive-topline-phase-3-study-results/ 2024-09-03T21:00:00+00:00 https://www.organon.com/suppliers/news/organon-enters-into-licensing-agreement-with-bao-pharmaceutical-and-its-wholly-owned-subsidiary-centergene-pharmaceuticals-for-innovative-investigational-asset-in-assisted-reproductive-technology-art/ 2024-09-12T06:00:00+00:00 https://www.organon.com/suppliers/news/organon-issues-2023-esg-report-highlighting-strides-in-womens-health-equity-and-environmental-stewardship/ 2024-09-17T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-acquire-dermavant-including-its-innovative-dermatologic-therapy-vtama-tapinarof-cream-1/ 2024-09-18T07:30:00+00:00 https://www.organon.com/suppliers/news/primary-endpoint-met-in-phase-3-comparative-clinical-study-of-perjeta-pertuzumab-biosimilar-candidate-hlx11/ 2024-09-30T06:00:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-third-quarter-2024-results-and-host-conference-call-on-october-31-2024/ 2024-10-09T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-completes-acquisition-of-dermavant-including-innovative-dermatologic-therapy-vtama-tapinarof-cream-1/ 2024-10-28T09:25:00+00:00 https://www.organon.com/suppliers/news/us-fda-accepts-biologics-license-application-bla-for-hlx14-biosimilar-candidate-of-prolia-xgeva-denosumab/ 2024-10-30T06:00:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-third-quarter-ended-september-30-2024/ 2024-10-31T07:30:00+00:00 https://www.organon.com/suppliers/news/update-on-fda-review-of-vtama-tapinarof-cream-1-for-the-treatment-of-atopic-dermatitis-in-adults-and-children-2-years-of-age-and-older/ 2024-11-05T07:29:00+00:00 https://www.organon.com/suppliers/news/fda-approves-vtama-tapinarof-cream-1-for-the-treatment-of-atopic-dermatitis-in-adults-and-children-2-years-of-age-and-older/ 2024-12-16T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference/ 2024-12-19T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-fourth-quarter-and-full-year-2024-results-and-host-conference-call-on-february-13-2025/ 2025-01-23T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-fourth-quarter-and-full-year-ended-december-31-2024/ 2025-02-13T07:30:00+00:00 https://www.organon.com/suppliers/news/new-analysis-of-organons-vtama-tapinarof-cream-1-phase-3-data-shows-atopic-dermatitis-disease-activity-remained-low-after-treatment-free-interval-in-adults-and-children-2-years-of-ag/ 2025-03-08T09:00:00+00:00 https://www.organon.com/suppliers/news/european-medicines-agency-ema-validates-henlius-and-organon-filing-for-perjeta-pertuzumab-biosimilar-candidate-hlx11/ 2025-03-28T06:00:00+00:00 https://www.organon.com/suppliers/news/organon-acquires-tofidence-tocilizumab-bavi-a-commercialized-biosimilar-to-actemra-tocilizumab-injection-for-intravenous-infusion-in-the-u-s/ 2025-04-01T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-to-report-first-quarter-2025-results-and-host-conference-call-on-may-1-2025/ 2025-04-15T07:31:00+00:00 https://www.organon.com/suppliers/news/organon-appoints-ramona-a-sequeira-to-the-companys-board-of-directors/ 2025-04-15T17:00:00+00:00 https://www.organon.com/suppliers/news/organon-reports-results-for-the-first-quarter-ended-march-31-2025/ 2025-05-01T07:00:00+00:00 https://www.organon.com/suppliers/news/us-food-and-drug-administration-fda-grants-interchangeability-designation-to-samsung-bioepis-and-organon-hadlima-adalimumab-bwwd-injection/ 2025-05-27T07:30:00+00:00 https://www.organon.com/suppliers/news/organon-and-evvy-announce-collaboration-to-expand-access-of-xaciato-clindamycin-phosphate-vaginal-gel-2-a-treatment-for-bacterial-vaginosis/ 2025-06-12T09:00:00+00:00